O2-2-3Clarification of Mechanisms of Acquired Resistance for Afatinib Using Plasma Samples

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.13-18 Mechanisms of Acquired Resistance to Afatinib Clarified With Liquid Biopsy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas V2 After Acquired Resistance to Afatinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Genomic Overview of Acquired Antibiotic Resistance Mechanisms in Lactobacillus

2019English

Plasma-Sensitive Escherichia Coli Mutants Reveal Plasma Resistance Mechanisms

Journal of the Royal Society Interface
BiochemistryBiophysicsBiomaterialsBiotechnologyBioengineeringBiomedical Engineering
2019English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Plasma Cleaning of Carbonaceous Samples Using a Shield

Microscopy and Microanalysis
Instrumentation
2003English

Phase 1 Trial of Dasatinib Combined With Afatinib for Epidermal Growth Factor Receptor- (EGFR-) Mutated Lung Cancer With Acquired Tyrosine Kinase Inhibitor (TKI) Resistance

British Journal of Cancer
Cancer ResearchOncology
2019English

Publisher Correction: O2−O2 and O2−N2 Collision-Induced Absorption Mechanisms Unravelled

Nature Chemistry
ChemistryChemical Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy